共 50 条
- [21] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL AND CLINICAL BONE-MARROW TRANSPLANTATION [J]. PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1985, 6 (02): : 257 - 274
- [22] SIGNIFICANCE OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION [J]. ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1627 - 1633
- [23] THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION [J]. LANCET, 1988, 1 (8581): : 359 - 359
- [26] CHRONIC GRAFT-VERSUS-HOST DISEASE IN ALLOGENIC BONE-MARROW TRANSPLANTATION [J]. HAUTARZT, 1984, 35 (06): : 322 - 323
- [27] CYCLOSPORINE AND GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (24): : 1607 - 1607
- [28] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 197 (01): : 12 - 18
- [29] T-cells, graft-versus-host disease, and graft-versus-leukemia - New approaches for blood and marrow transplantation [J]. MOLECULAR BIOLOGY OF HEMATOPOIESIS 5, 1996, : 1 - 10